长期生活方式干预对超重或肥胖2型糖尿病成人周围神经病变的影响:Look AHEAD研究
Look AHEAD研究将5145例超重或肥胖的2型糖尿病成人随机分为强化生活方式干预(ILI)组和糖尿病支持教育(DSE)对照组,评估长期减重干预对糖尿病周围神经病变(DPN)的影响。结果显示,干预1年时ILI组MNSI问卷评分显著低于DSE组,且差异在最初3年及随访结束时仍显著;但干预终止后1-2.3年进行的体格检查指标除双足趾合并分析触觉外无显著组间差异。
要点
- ILI组在干预1年时体重下降达8.6±6.9%,MNSI问卷评分为1.7±0.04,显著低于DSE组的2.0±0.04(p≤0.001)。
- MNSI问卷评分在最初3年及随访结束时ILI组仍显著低于DSE组。
- 干预终止后1-2.3年,MNSI体格检查评分≥2.5的比例及单足触觉无显著组间差异,仅双足合并触觉ILI组更优。
核心结论
- ILI使基于问卷的DPN显著减少,且与减重幅度相关。
- 在ILI和DSE两组中,MNSI评分变化均与HbA1c和血脂变化相关。
- ILI对干预终止后1-2.3年进行的DPN体格检查指标无显著影响,但双足合并分析时触觉在ILI组显著更优。
- 体格检查数据解读的潜在局限是缺乏基线研究可供比较。
研究设计与样本
- 多中心随机对照研究Look AHEAD,2001年起纳入5145例45-76岁超重或肥胖2型糖尿病患者,随机分为ILI组(n=2570)和DSE对照组(n=2575)。
- 随机化按临床中心分层,结局数据采集人员不知分组,但患者、当地中心干预人员及协调中心数据管理与统计分析人员未设盲。
- 干预于2012年9月终止(随机化后9-11年),两组继续随访主要和次要结局。
- 神经病变评估包括基线时5145例完成的MNSI问卷(每年重复)及干预终止后1-2.3年在3775例中进行的MNSI体格检查和轻触觉测试。
主要发现
- 基线MNSI问卷评分ILI组为1.9±0.04,DSE组为1.8±0.04,差异无统计学意义。
- 干预1年时ILI组体重下降8.6±6.9%,DSE组为0.7±4.8%;MNSI评分分别为1.7±0.04和2.0±0.04(p≤0.001)。
- 此后两组评分逐渐升高,但最初3年及随访结束时ILI组仍显著低于DSE组。
- 两组MNSI评分变化与体重、HbA1c和血脂变化均显著相关。
- MNSI体格检查评分≥2.5(提示糖尿病神经病变)的比例无显著组间差异;左或右足趾单独轻触觉无差异,双足合并分析时ILI组轻触觉保留更好。
局限性
- 体格检查数据解读的潜在限制因素是缺乏基线研究可供比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this study was to evaluate the effects on diabetic peripheral neuropathy (DPN) of a long-term intensive lifestyle intervention (ILI) programme designed to achieve and maintain weight loss. METHODS: Beginning in 2001, a total of 5145 overweight or obese people with type 2 diabetes, aged 45-76 years, participating in the multicentre Look AHEAD (Action for Health in Diabetes) study were randomised to ILI (n = 2570) or to a diabetes support and education (DSE) control group (n = 2575) using a web-based management system at the study coordinating centre at Wake Forest School of Medicine (Winston-Salem, NC, USA). Randomisation was stratified by clinical centre and was not revealed to the clinical staff responsible for obtaining data on study outcomes. Because of the nature of the study, patients and the local centre interventionists were not blinded to the study group assignments. In addition, the coordinating centre staff members responsible for data management and statistical analyses were not blinded to the study group assignments. The interventions were terminated in September 2012, 9-11 years after randomisation, but both groups continued to be followed for both primary and secondary outcomes. Neuropathy evaluations included the Michigan Neuropathy Screening Instrument (MNSI) questionnaire completed at baseline in 5145 participants (ILI n = 2570, DSE n = 2575) and repeated annually thereafter and the MNSI physical examination and light touch sensation testing conducted in 3775 participants (ILI n = 1905, DSE n = 1870) 1-2.3 years after discontinuation of the intervention. RESULTS: At baseline, the MNSI questionnaire scores were 1.9 ± 0.04 and 1.8 ± 0.04 in the ILI and DSE groups, respectively (difference not statistically significant). After 1 year, when weight loss was maximal in the ILI group (8.6 ± 6.9%) compared with DSE (0.7 ± 4.8%), the respective MNSI scores were 1.7 ± 0.04 and 2.0 ± 0.04 (p ≤ 0.001). Subsequently, the scores increased gradually in both groups, but remained significantly lower in the ILI group for the first 3 years and at the end of follow-up. In both groups, there was a significant association between changes in the MNSI scores and changes in body weight, HbA1c and serum lipids. There were no significant between-group differences in the proportions of participants with MNSI physical examination scores ≥2.5, considered to be indicative of diabetic neuropathy. The light touch sensation measured separately in either the right or left big toes (halluces) did not differ between ILI and DSE, but when the data were combined for both toes, light touch was better preserved in the ILI group. CONCLUSIONS/INTERPRETATION: ILI resulted in a significant decrease in questionnaire-based DPN, which was associated with the magnitude of weight loss. In both the ILI and DSE groups, changes in the MNSI score were also related to changes in HbA1c and lipids. There were no significant effects of ILI on physical examination measures of DPN conducted 1-2.3 years after termination of the active intervention, except for light touch sensation, which was significantly better in the ILI group when measurements were combined for both toes. However, a potential limiting factor to the interpretation of the physical examination data is that no baseline studies are available for comparison. TRIAL REGISTRATION: ClinicalTrials.gov NCT00017953. FUNDING: This work was funded by the National Institutes of Health through cooperative agreements with the National Institute of Diabetes and Digestive and Kidney Diseases.
引用
- Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study. Diabetologia. 2017. PMID: 28349174. doi:10.1007/s00125-017-4253-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。